An Open-label, 1-sequence, 3-period, 3-treatment, Crossover Study to Assess the Effects of Ketoconazole on the Pharmacokinetics of NKTR-118 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2016
At a glance
- Drugs Ketoconazole; Naloxegol
- Indications Constipation; Seborrhoeic dermatitis
- Focus Pharmacokinetics
- 17 Dec 2015 Results of this and other two trials (see profile 213577 and 217552) were published in the Journal of Clinical Pharmacology
- 07 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.